Literature DB >> 11154113

Characterization of unfractionated heparin: comparison of materials from the last 50 years.

B Mulloy1, E Gray, T W Barrowcliffe.   

Abstract

Physicochemical and anticoagulant characteristics of 27 samples from recent batches of commercially produced unfractionated heparin have been determined as part of the process of establishment of the 5th International Standard Unfractionated Heparin. They have been compared with current heparin standards (European Pharmacopoeia, United States Pharmacopoeia, Chinese), with the 4th International Standard Unfractionated Heparin. and with the three predecessor International Standards. The results indicate that the 4th International Standard Unfractionated Heparin, established in 1982, has significantly lower molecular weight and specific activity than recently produced heparin; this is also true of all preceding International Standard Heparins and of the United States Pharmacopoeial standard. The composition of commercial unfractionated heparin may therefore have changed over time; reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11154113

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Antithrombin-binding oligosaccharides: structural diversities in a unique function?

Authors:  Marco Guerrini; Pierre A J Mourier; Giangiacomo Torri; Christian Viskov
Journal:  Glycoconj J       Date:  2014-10       Impact factor: 2.916

2.  Complete Molecular Weight Profiling of Low-Molecular Weight Heparins Using Size Exclusion Chromatography-Ion Suppressor-High-Resolution Mass Spectrometry.

Authors:  Joseph Zaia; Kshitij Khatri; Joshua Klein; Chun Shao; Yuewei Sheng; Rosa Viner
Journal:  Anal Chem       Date:  2016-10-17       Impact factor: 6.986

3.  Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.

Authors:  Simon J Clark; Rahat Perveen; Svetlana Hakobyan; B Paul Morgan; Robert B Sim; Paul N Bishop; Anthony J Day
Journal:  J Biol Chem       Date:  2010-07-26       Impact factor: 5.157

4.  Unique extracellular matrix heparan sulfate from the bivalve Nodipecten nodosus (Linnaeus, 1758) safely inhibits arterial thrombosis after photochemically induced endothelial lesion.

Authors:  Angélica M Gomes; Eliene O Kozlowski; Vitor H Pomin; Cintia Monteiro de Barros; José L Zaganeli; Mauro S G Pavão
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

Review 5.  Heparan sulfate and heparin interactions with proteins.

Authors:  Maria C Z Meneghetti; Ashley J Hughes; Timothy R Rudd; Helena B Nader; Andrew K Powell; Edwin A Yates; Marcelo A Lima
Journal:  J R Soc Interface       Date:  2015-09-06       Impact factor: 4.118

Review 6.  Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs.

Authors:  Paulo A S Mourão
Journal:  Mar Drugs       Date:  2015-05-06       Impact factor: 5.118

7.  Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.

Authors:  Simon J Clark; Liam A Ridge; Andrew P Herbert; Svetlana Hakobyan; Barbara Mulloy; Rachel Lennon; Reinhard Würzner; B Paul Morgan; Dusan Uhrín; Paul N Bishop; Anthony J Day
Journal:  J Immunol       Date:  2013-01-30       Impact factor: 5.422

8.  Bovine and porcine heparins: different drugs with similar effects on human haemodialysis.

Authors:  Ana M F Tovar; Lisandra A C Teixeira; Simone M Rembold; Maurilo Leite; Jocemir R Lugon; Paulo A S Mourão
Journal:  BMC Res Notes       Date:  2013-06-13

9.  Heparin and related drugs: beyond anticoagulant activity.

Authors:  Clive Page
Journal:  ISRN Pharmacol       Date:  2013-07-30

10.  Development of a microtiter plate-based glycosaminoglycan array for the investigation of glycosaminoglycan-protein interactions.

Authors:  Andrew Marson; David E Robinson; Patrick N Brookes; Barbara Mulloy; Michelle Wiles; Simon J Clark; Helen L Fielder; Lisa J Collinson; Stuart A Cain; Catherine M Kielty; Sally McArthur; David J Buttle; Robert D Short; Jason D Whittle; Anthony J Day
Journal:  Glycobiology       Date:  2009-09-03       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.